HER2 negative breast cancer is a common subtype of breast cancer that differs in how it grows and responds to treatment. Understanding its symptoms and diagnostic tests can help individuals recognize early warning signs and seek timely medical evaluation. This article explains what HER2 negative breast cancer is, the physical changes it may cause, and the medical tests used to diagnose it accurately. By learning about symptoms such as lumps, skin changes, and breast discomfort, along with imaging and laboratory testing methods, readers can gain clearer insight into how this condition is identified and assessed in clinical practice.
Guide to understanding HER2 negative breast cancer focuses on awareness, early detection, and accurate diagnosis. HER2 negative breast cancer means the cancer cells do not have high levels of the HER2 protein, which influences how the disease behaves and how it is tested. Knowing the symptoms and tests involved can support informed health discussions and timely medical attention.
HER2 negative breast cancer symptoms are often similar to other breast cancer types. These symptoms may develop gradually and should not be ignored if they persist.
Common symptoms include:
A new lump or thickened area in the breast or underarm
Change in breast size, shape, or appearance
Skin changes such as redness, dimpling, or puckering
Nipple pain, inversion, or unusual discharge
Persistent breast pain not related to the menstrual cycle
It is important to note that not all breast changes indicate cancer. However, any unusual or lasting symptom should be evaluated by a healthcare professional for clarity and reassurance.
Accurate diagnosis involves a combination of imaging and laboratory tests. These tests help confirm the presence of cancer and determine whether it is HER2 negative.
Common diagnostic tests include:
Clinical breast examination to assess lumps or visible changes
Mammography to detect abnormal breast tissue
Ultrasound for clearer imaging of breast masses
Breast biopsy to collect tissue samples for analysis
HER2 testing on biopsy samples to confirm HER2 status
Laboratory analysis plays a key role, as HER2 testing determines whether the cancer cells lack excess HER2 protein, guiding classification and understanding of the disease.
HER2 negative breast cancer is identified through careful evaluation of symptoms and precise diagnostic testing. Recognizing early signs such as lumps or skin changes and understanding the role of imaging and biopsy tests can support timely diagnosis. While symptoms alone cannot confirm the condition, medical testing provides accurate answers and clarity. This article is intended to provide general information only and encourage informed conversations with qualified healthcare professionals for proper evaluation and guidance.